Filter
1506
Filtered Results: 1506
Text search:
Anti-Tuberculosis
medicines
Featured
Recommendations
174
New Publications
476
Language
Document type
No document type
1020
Guidelines
171
Studies & Reports
166
Manuals
70
Strategic & Response Plan
29
Training Material
18
Fact sheets
14
Situation Updates
10
Infographics
5
Brochures
1
App
1
Resource Platforms
1
Countries / Regions
India
96
Kenya
50
Western and Central Europe
42
Ethiopia
41
Uganda
40
South Africa
35
Nigeria
33
Tanzania
31
Global
30
Zambia
29
Nepal
25
Ghana
24
Eastern Europe
24
Liberia
23
Malawi
22
Myanmar / Burma
21
Bangladesh
20
Namibia
19
Rwanda
18
Philippines
18
Ukraine
16
Sierra Leone
16
Africa
15
Asia
15
Latin America and the Carribbean
15
Lesotho
14
Russia
14
Cambodia
13
Colombia
10
Zimbabwe
10
South–East Asia Region
10
Senegal
9
Botswana
9
Indonesia
9
Mozambique
8
Venezuela
7
Germany
6
Eswatini/ Swaziland
6
Benin
5
Peru
5
Moldova
5
Pakistan
5
Tajikistan
4
Thailand
4
Cameroon
4
Syria
4
East and Southern Africa
4
Bolivia
4
Albania
3
Afghanistan
3
Paraguay
3
Vietnam
3
Ecuador
3
Timor Leste/ East Timor
2
Haiti
2
Jordan
2
West and Central Africa
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
Turkmenistan
2
Argentina
2
Lebanon
2
Papua New Guinea
2
Yemen
2
Georgia
2
Poland
2
Libya
2
Somalia
2
North Macedonia
1
El Salvador
1
Gambia
1
Chile
1
Iran
1
Laos
1
Estonia
1
Burkina Faso
1
Uzbekistan
1
Qatar
1
USA
1
Hungary
1
Saudi Arabia
1
Congo, Democratic Republic of
1
Western Pacific Region
1
North America
1
Denmark
1
Maldives
1
Southern Africa
1
Brazil
1
Sri Lanka
1
Djibouti
1
Egypt
1
Sudan
1
Palestine
1
Mali
1
Bhutan
1
South Sudan
1
Iraq
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
652
Clinical Guidelines
174
Public Health
72
Women & Child Health
48
Pharmacy & Technologies
24
Capacity Building
17
Key Resources
15
Toolboxes
TB
362
HIV
179
AMR
64
Pharmacy
62
COVID-19
39
Mental Health
36
NTDs
31
NCDs
24
Caregiver
21
Global Health Education
20
Refugee
16
Ebola
14
Rapid Response
13
Conflict
13
Polio
13
Planetary Health
11
Disability
7
Natural Hazards
6
Health Financing Toolbox
6
Specific Hazards
3
Cholera
1
Social Ethics
1
Health Financing
1
Zika
1
Tuberculosis (TB) is, and should be, a curable disease; however, each year significant numbers of patients acquire or develop drug-resistant TB, which has a much lower cure rate. Patients with drug-resistant TB have a high prevalence of symptoms; hence, staff caring for these patients should h...
Technology landscape
The PHC STGs and EML should be used by healthcare workers providing care at clinics, community health centres, and gateway clinics at hospitals.
Pharmaceutical and Therapeutics Committees (PTCs) are responsible for ensuring the availability of medicines listed in the PHC EML at those facilities, as...
The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published in 2017 and provides the la...
The Abuja declaration identifies that the prevention and control of HIV/AIDS, tuberculosis and related infectious diseases must come with additional financial resources. Therefore, African governments agreed on setting the target of allocating at least 15 per cent of each country’s annual budget ...
This brief update on tuberculosis (TB) in the African region covers the state of TB in the WHO African region, strategic priorities and targets and the impact of COVID-19 on essential services. This is followed by key figures for the region, the role of WHO in country support and, recognizing the im...
People affected by impairments and disabilities associated with TB are even more likely to belong to marginalized segments of society and are more likely to have their human rights unprotected. The challenges faced by people affected by TB include the consequences of impairment and disability associ...
About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop TB disease in their lifetime. The risk for TB disease after infection depends on several factors, the most important being the person’s im...
The goal of this addendum is to help management and staff
minimize the risk of TB transmission at facilities in resource limited settings in which a.) HIV-infected persons receive diagnosis, care, treatment,
and/or support, and b.) there is a high prevalence of HIV infection, both known
and...
Following review of the latest evidence, WHO recommends that TB-LAMP can be used as a replacement for microscopy for the diagnosis of pulmonary TB in adults with signs and symptoms of TB. It can also be considered as a follow-on test to microscopy in adults with signs and symptoms of pulmonary TB, e...
Advances in Infectious Diseases, 2015, 5, 57-62
Published Online March 2015 in SciRes.
BMC Infectious Diseases 2012, 12:352/1471-2334/12/352
6 July 2021. The “WHO consolidated guidelines on tuberculosis. Module 3: Diagnosis - Rapid diagnostics for tuberculosis detection 2021 update” is the latest document replacing the one issued in 2020. Three new nucleic acid amplification test (NAAT) classes are endorsed by WHO and included in the...
Pan American Journal of Public Health.
Objetivo. Identificar os fatores associados ao êxito do tratamento da tuberculose multirresistente (TBMR) relacionados ao paciente e à equipe de saúde nos seis municípios da Colômbia com o maior número de casos. Métodos. Mediante regresiones logísticas...
Estas directrices sustituyen a los anteriores documentos de política de la OMS sobre el manejo de la ILTB en las personas con la infección por el VIH, los contactos del hogar de personas con TB y otros grupos de riesgo. Las Directrices unificadas de la OMS sobre la tuberculosis: Tratamiento preven...
Rev Panam Salud Publica. 2021;45:e74.
Some characteristics of patients and healthcare providers influence treatment success in MDR-TB cases. Physicians’ and nurses’ knowledge about MDR-TB must be improved, and follow-up of MDR-TB patients who are living with HIV and of those affiliated with the...
